Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2012
02/07/2012CA2431669C Pesticidal and antiparasitic compositions comprising chitinase or chitin and sulfide
02/07/2012CA2383850C Prevention and treatment of mycoplasma-associated diseases
02/05/2012CA2713777A1 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
02/02/2012WO2012016048A1 Anti- viral azide-containing compounds
02/02/2012WO2012015820A1 Composition and method for photodynamic disinfection
02/02/2012WO2012015270A2 Permissive cell line to the porcine reproductive and respiratory syndrome virus
02/02/2012WO2012015242A2 Novel antimicrobial composition, and method for preparing same
02/02/2012WO2012015037A1 Antimicrobial activity enhancing agent
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
02/02/2012WO2012014978A1 Immune adjuvant
02/02/2012WO2012014805A1 Nitric oxide generation regulator
02/02/2012WO2012014238A1 Composition for the treatment and prevention of herpes simplex labialis
02/02/2012WO2012014109A1 Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
02/02/2012WO2012014016A1 Method of treating animal drinking water with interval dosing of a biocide
02/02/2012WO2012013848A1 Difluorobenzyl ethanolamine derivatives with antimicrobial activity
02/02/2012WO2012013643A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012WO2012012872A1 Recombinant bacterium and uses thereof
02/02/2012WO2011156594A3 Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
02/02/2012WO2011149354A8 Mirnas involved in the blood brain barrier function
02/02/2012WO2011130419A3 Broad spectrum antiviral and antiparasitic agents
02/02/2012WO2011123536A8 Polycyclic tetracycline compounds
02/02/2012WO2010146257A8 Simalikalactone e and use thereof as a medicament
02/02/2012US20120029472 Tnfr25 agonists to enhance immune responses to vaccines
02/02/2012US20120029437 Kits for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029078 Compositions comprising myristic acid and uses thereof
02/02/2012US20120029077 Animal Feed Additive and Animal Feed Comprising Alkyl Esters of Medium Chain Fatty Acids, and their Use in Animal Feed
02/02/2012US20120029075 Compositions containing c1 to c7 organic acid monoglycerides and glycerol, their preparation and use as antibacterials and anti-mould agents
02/02/2012US20120029072 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029023 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120028999 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
02/02/2012US20120028998 Co-crystal of etravirine and nicotinamide
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028979 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
02/02/2012US20120028978 Substituted bicyclic hcv inhibitors
02/02/2012US20120028973 Nitroimidazooxazines and their uses in anti-tubercular therapy
02/02/2012US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028957 Inhibitors Of The Influenza A Virus M2 Proton Channel
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery
02/02/2012US20120028943 Medicinal Cream Made Using Fluticasone Propionate And Chitosan And A Process To Make The Same
02/02/2012US20120028942 Medicinal Cream Made Using Neomycin Sulphate, Betamethasone Valerate, And Chitosan, And A Process To Make The Same
02/02/2012US20120028941 Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient
02/02/2012US20120028938 Pyrazole compounds as crth2 antagonists
02/02/2012US20120028929 Tetracycline stabilizing formulations
02/02/2012US20120028928 Process for Isolating Tigecycline and Tigecycline Made Therefrom
02/02/2012US20120028914 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
02/02/2012US20120028912 Methods of modulating bromodomains
02/02/2012US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof
02/02/2012US20120028889 Integrase cofactor
02/02/2012US20120028888 Apj receptor compounds
02/02/2012US20120028887 Lipopeptide inhibitors of hiv-1
02/02/2012US20120028883 Complex and production process
02/02/2012US20120028882 Method for removing endotoxin from proteins
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027875 Compositions for Treatment of Skin and Ear Infections
02/02/2012US20120027855 Pharmaceutical compositions for gastrointestinal drug delivery
02/02/2012US20120027853 Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
02/02/2012US20120027846 Anti-viral azide containing compounds
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027841 Novel mucosal vaccination approach for herpes simplex virus type-2
02/02/2012US20120027836 Novel edwardsiella ictaluri e-ict-vl33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
02/02/2012US20120027833 Drug-eluting films
02/02/2012US20120027813 Adjuvanted influenza vaccines for pediatric use
02/02/2012US20120027811 Formulations of Viable Cells for Oral Delivery
02/02/2012US20120027809 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof
02/02/2012US20120027806 Dose selection of adjuvanted synthetic nanocarriers
02/02/2012US20120027802 Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
02/02/2012US20120027800 Neisserial vaccine compositions comprising a combination of antigens
02/02/2012US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam
02/02/2012US20120027796 Novel lipids and compositions for the delivery of therapeutics
02/02/2012US20120027795 Simple vaccines from dna launched suicidal flaviviruses
02/02/2012US20120027794 Tuberculosis vaccine with improved efficacy
02/02/2012US20120027793 Compositions comprising chlamydia antigens
02/02/2012US20120027792 Expression vectors able to elicit improved immune response and methods of using same
02/02/2012US20120027790 Immunological herpes simplex virus antigens and methods for use thereof
02/02/2012US20120027789 Antigenic peptide of hsv-2 and methods for using same
02/02/2012US20120027788 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
02/02/2012US20120027786 Genetically programmable pathogen sense and destroy
02/02/2012US20120027785 Chimera comprising bacterial cytotoxin and methods of using the same
02/02/2012US20120027781 Neuroprotective and neurorestorative method and compositions
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027776 Diabetic model
02/02/2012US20120027771 Affinity purified human polyclonal antibodies against viral, bacterial and/or fungal infections and methods of making and using the same
02/02/2012US20120027768 Monoclonal antibody production by ebv transformation of b cells
02/02/2012US20120027752 Methods and compounds for treating paramyxoviridae virus infections
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012US20120027748 Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
02/02/2012US20120027722 Hepatitis c virus combination therapy
02/02/2012US20120027721 HCV Inhibitor and Therapeutic Agent Combinations
02/02/2012US20120027715 Polymer films with embedded iodinated resin and methods of manufacturing same
02/02/2012US20120027705 Administration of cells and cellular extracts for rejuvenation
1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 1798